Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2012 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (357)	9/28/2012 6:23:16 PM
From: BulbaMan	1 Recommendation Read Replies (2) \| Respond to of 513

9/28/12 Contest Update Although stocks have tracked Obama’s poll numbers higher most of the year, this week was an exception. Over the past 7 days, The New York Times election forecasting guru, Nate Silver, boosted his estimate of Obama’s chances of victory by 7.8% to 83.9%, but stocks moved in the opposite direction. And, in particular, a few high-flying Contest portfolio stocks ran into some strong headwinds. Nonetheless, at Friday’s close, the Contest median was still up an impressive 46.73% YTD (vs. up 51.23% YTD a week ago). In comparison, the Nasdaq Biotech Index was up 37.01% YTD (vs. up 38.70% YTD a week ago), while the Nasdaq Composite Index was up 19.62% YTD (vs. up 22.06% YTD a week ago). After PPHM announced that some of its clinical trial data was sketchy, its stock gave up all of its YTD gains. And with a 20% initial allocation to PPHM, last week’s Contest leader, ROBERT’s portfolio, suffered considerably. Consequently, RKRW’s portfolio, up 104.99% YTD, is back in the lead, with GENE’s portfolio, up 93.96% YTD, holding on to second place and DONS’ portfolio, up 93.19% YTD, remaining in third place. At Friday's close, 2 of the 38 Contest portfolios were in the red, with 24 of the 38 portfolios still beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week. And, as it’s the end of Q3, I’ve posted the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost YTD. (Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables, when posted.) Portfolio adjustments: MDVN 2-1 split. Have a terrific weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 9/28/12 Rank Name Profit/Loss 1 RKRW 104,991 2 GENE 93,962 3 DONS 93,191 4 NP1986 87,031 5 LJM 77,879 6 DOUGH 70,787 7 PGO 70,392 8 FRED 67,731 9 ANON 67,217 10 TNSAF 66,469 Week's Top 5 Gainers Symbol 9/21/12 9/28/12 Wk. %chg. SKBI 1.52 1.92 26.32% NPC.TO 0.25 0.29 18.37% BLRX 2.32 2.63 13.36% NGNM 2.71 3.01 11.07% TZYM 4.08 4.46 9.31% Week's Worst 5 Losers Symbol 9/21/12 9/28/12 Wk. %chg. PPHM 5.39 1.03 -80.89% CPRX 1.92 1.51 -21.35% ISR 0.87 0.72 -17.24% ONTY 6.16 5.13 -16.72% AMRS 4.09 3.44 -15.89% YTD Top 5 Gainers Symbol YE2011 9/28/12 YTD %chg. BDSI 0.81 6.32 685.00% THLD 1.22 7.24 493.44% SNSS 1.17 5.63 381.20% ARNA 1.87 8.32 344.92% PCYC 14.82 64.50 335.22% YTD Worst 5 Losers Symbol YE2011 9/28/12 YTD %chg. CRME 2.63 0.33 -87.41% CHTP 5.13 1.20 -76.61% NGSX 0.82 0.21 -74.39% AMRS 11.54 3.44 -70.19% PGNX 8.54 2.88 -66.28%